| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 2.997 | 48.846 | 85.430 | 62.992 |
| Total Income - EUR | - | - | - | - | - | - | 2.997 | 48.846 | 85.435 | 62.995 |
| Total Expenses - EUR | - | - | - | - | - | - | 3.814 | 24.852 | 38.606 | 32.780 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -817 | 23.994 | 46.829 | 30.215 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -907 | 23.252 | 46.060 | 28.457 |
| Employees | - | - | - | - | - | - | 1 | 1 | 2 | 1 |
Check the financial reports for the company - Quantisoma Nexus S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 583 | 16.728 | 12.435 | 6.394 |
| Current Assets | - | - | - | - | - | - | 1.111 | 19.073 | 49.694 | 34.765 |
| Inventories | - | - | - | - | - | - | 429 | 4.085 | 3.971 | 2.479 |
| Receivables | - | - | - | - | - | - | 0 | 1.503 | 38.798 | 28.282 |
| Cash | - | - | - | - | - | - | 682 | 13.485 | 6.925 | 4.004 |
| Shareholders Funds | - | - | - | - | - | - | -867 | 22.383 | 46.108 | 28.506 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 2.561 | 13.418 | 16.021 | 12.660 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Quantisoma Nexus S.r.l.